A drug called ribociclib, currently used to treat breast cancer, could slow the progression of certain pediatric high-grade gliomas, an aggressive type of childhood brain cancer, a new study has ...
JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...
This newest approval for amivantamab is the second approval in 6 months for the EGFR and MET bispecific antibody. Data from the MARIPOSA study (NCT04487080) support this newest approval, and ...
Fig 2. Summary of guideline recommendations. AEs, adverse events; CDK4/6, cyclin-dependent kinase 4/6; ESR1, estrogen receptor 2; ER, estrogen receptor; ET, endocrine ...